| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 419 | 3.618 | 23.007 | 37.651 | 60.339 | 77.491 | 99.675 | 140.285 |
| Total Income - EUR | - | - | 419 | 3.618 | 23.007 | 37.651 | 60.339 | 77.491 | 99.678 | 140.285 |
| Total Expenses - EUR | - | - | 317 | 3.377 | 699 | 614 | 1.373 | 975 | 8.827 | 9.963 |
| Gross Profit/Loss - EUR | - | - | 103 | 241 | 22.308 | 37.037 | 58.966 | 76.516 | 90.851 | 130.321 |
| Net Profit/Loss - EUR | - | - | 90 | 132 | 21.618 | 35.968 | 57.193 | 74.238 | 89.874 | 126.197 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 |
Check the financial reports for the company - Bucurigyn Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 296 | 0 | 0 | 0 | 8 | 41 | 40 | 40 |
| Current Assets | - | - | 456 | 1.094 | 22.133 | 57.891 | 135.432 | 75.198 | 91.906 | 198.160 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 3.084 | 3.128 | 31.150 | 60.596 | 8.899 | 136.708 |
| Cash | - | - | 456 | 1.094 | 19.049 | 54.763 | 104.283 | 14.602 | 83.007 | 61.452 |
| Shareholders Funds | - | - | 134 | 264 | 21.876 | 57.430 | 57.241 | 74.287 | 89.923 | 126.245 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 618 | 830 | 257 | 461 | 78.199 | 951 | 2.024 | 71.955 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Bucurigyn Srl